NovaBay Pharmaceuticals, Inc. (NBY) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 521K | 0 | 0 | 2.31M | 2.44M | 2.4M | 2.63M | 3.73M | 3.25M | 3.53M | 2.34M | 3.64M | 3.83M | 3.66M | 2.63M | 2.64M | 2.27M | 2.13M | 1.81M | 1.89M |
| Revenue Growth % | -78.66% | -100% | -100% | -38.05% | -25.01% | -32.09% | 12.48% | 2.31% | -14.92% | -3.5% | -11.03% | 37.94% | 68.92% | 71.68% | 45.49% | 39.88% | 4.38% | -46.46% | -4.49% | 10.8% |
| Cost of Goods Sold | 479K | 0 | 0 | 807K | 848K | 808K | 837K | 1.91M | 1.42M | 1.79M | 739K | 1.89M | 1.45M | 1.82M | 1.11M | 1.21M | 712K | 614K | 455K | 813K |
| COGS % of Revenue | 91.94% | - | - | 34.95% | 34.74% | 33.67% | 31.81% | 51.3% | 43.53% | 50.79% | 31.59% | 51.83% | 37.92% | 49.81% | 42.34% | 45.97% | 31.43% | 28.79% | 25.18% | 43.06% |
| Gross Profit | 42K | 0 | 0 | 1.5M | 1.59M | 1.59M | 1.79M | 1.81M | 1.84M | 1.74M | 1.6M | 1.75M | 2.38M | 1.84M | 1.52M | 1.43M | 1.55M | 1.52M | 1.35M | 1.07M |
| Gross Margin % | 8.06% | - | - | 65.05% | 65.26% | 66.33% | 68.19% | 48.7% | 56.47% | 49.21% | 68.41% | 48.17% | 62.08% | 50.19% | 57.66% | 54.03% | 68.57% | 71.21% | 74.82% | 56.94% |
| Gross Profit Growth % | -97.36% | -100% | -100% | -17.25% | -13.33% | -8.45% | 12.13% | 3.42% | -22.61% | -5.39% | 5.54% | 22.99% | 52.93% | 21% | 12.13% | 32.74% | -4.96% | -21.86% | 3.13% | -3.24% |
| Operating Expenses | 1.3M | 1.89M | 3.29M | 2.79M | 2.65M | 2.65M | 3.37M | 2.61M | 2.95M | 2.79M | 2.94M | 11.18M | 2.83M | 3.99M | 3.9M | 4.62M | 3.84M | 3.38M | 2.87M | 2.83M |
| OpEx % of Revenue | 249.14% | - | - | 120.87% | 108.73% | 110.21% | 127.9% | 70.11% | 90.75% | 78.95% | 125.91% | 306.92% | 74.02% | 108.96% | 148.27% | 174.97% | 169.62% | 158.37% | 158.94% | 150.05% |
| Selling, General & Admin | 1.21M | 1.89M | 2.7M | 2.78M | 2.65M | 2.64M | 3.35M | 2.61M | 2.94M | 2.77M | 2.94M | 4.38M | 2.79M | 3.95M | 3.87M | 4.61M | 3.83M | 3.36M | 2.87M | 2.8M |
| SG&A % of Revenue | 232.44% | - | - | 120.44% | 108.56% | 109.83% | 127.18% | 70% | 90.41% | 78.32% | 125.48% | 120.18% | 72.95% | 107.86% | 147.2% | 174.67% | 169.18% | 157.38% | 158.66% | 148.15% |
| Research & Development | 0 | 0 | 0 | 10K | 4K | 9K | 19K | 4K | 11K | 22K | 10K | 66K | 41K | 40K | 28K | 8K | 10K | 21K | 5K | 36K |
| R&D % of Revenue | - | - | - | 0.43% | 0.16% | 0.38% | 0.72% | 0.11% | 0.34% | 0.62% | 0.43% | 1.81% | 1.07% | 1.09% | 1.06% | 0.3% | 0.44% | 0.98% | 0.28% | 1.91% |
| Other Operating Expenses | 87K | 0 | 589K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.26M | -1.89M | -3.29M | -1.29M | -1.06M | -1.05M | -1.57M | -798K | -1.12M | -1.05M | -1.34M | -9.43M | -457K | -2.15M | -2.38M | -3.19M | -2.29M | -1.86M | -1.52M | -1.76M |
| Operating Margin % | -241.07% | - | - | -55.83% | -43.47% | -43.88% | -59.71% | -21.41% | -34.29% | -29.74% | -57.5% | -258.74% | -11.94% | -58.77% | -90.6% | -120.94% | -101.06% | -87.15% | -84.12% | -93.11% |
| Operating Income Growth % | -18.38% | -79.58% | -109.42% | -61.53% | 4.93% | -0.19% | -16.8% | 91.53% | -144.2% | 51.16% | 43.53% | -195.12% | 80.03% | -15.76% | -56.71% | -81.68% | -11.01% | -73.58% | 0.98% | 21.45% |
| EBITDA | -1.25M | -1.85M | -3.23M | -1.19M | -961K | -1.04M | -1.56M | -748K | -1.06M | -898K | -1.33M | -9.3M | -338K | -2.03M | -2.26M | -3.11M | -2.28M | -1.85M | -1.51M | -1.75M |
| EBITDA Margin % | -240.69% | - | - | -51.71% | -39.37% | -43.42% | -59.26% | -20.07% | -32.72% | -25.41% | -56.95% | -255.37% | -8.83% | -55.49% | -86% | -117.64% | -100.53% | -86.64% | -83.62% | -92.53% |
| EBITDA Growth % | -30.49% | -77.83% | -107.5% | -59.63% | 9.77% | -16.04% | -17.04% | 91.96% | -215.09% | 55.81% | 41.09% | -199.42% | 85.16% | -9.96% | -49.64% | -77.85% | -11.07% | -74.83% | 0.66% | 21.41% |
| D&A (Non-Cash Add-back) | 2K | 38K | 55K | 95K | 100K | 11K | 12K | 50K | 51K | 153K | 13K | 123K | 119K | 120K | 121K | 87K | 12K | 11K | 9K | 11K |
| EBIT | -1.33M | -1.96M | -3.33M | -1.29M | -1.07M | -1.28M | -2.66M | -798K | -1.12M | -1.23M | -1.34M | -2.69M | -457K | -2.15M | -2.38M | -3.19M | -2.29M | -1.86M | -1.52M | -1.76M |
| Net Interest Income | 0 | -55K | 0 | -33K | -138K | -300K | -433K | 0 | 0 | -501K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 55K | 0 | 33K | 138K | 300K | 433K | 0 | 0 | 501K | - | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -77K | -73K | -40K | -34K | -151K | -532K | -654K | -3.31M | -641K | -677K | 0 | 1.22M | 321K | -3K | 2.27M | 3.04M | 0 | 0 | 2K | 8K |
| Pretax Income | -1.33M | -1.96M | -3.33M | -1.32M | -1.21M | -1.58M | -3.09M | -4.11M | -1.76M | -1.73M | -1.34M | -8.21M | -136K | -2.15M | -111K | -158K | -2.29M | -1.86M | -1.52M | -1.75M |
| Pretax Margin % | -255.85% | - | - | -57.3% | -49.65% | -66.04% | -117.45% | -110.22% | -53.98% | -48.9% | -57.5% | -225.25% | -3.55% | -58.85% | -4.22% | -5.98% | -101.06% | -87.15% | -84.01% | -92.69% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -0.23% |
| Net Income | -1.29M | -1.92M | 7.67M | -1.21M | -1.21M | -1.58M | -3.21M | -4.11M | -1.76M | -2.04M | -1.74M | -8.21M | -136K | -2.15M | -111K | -158K | -2.29M | -1.86M | -1.52M | -1.75M |
| Net Margin % | -248.18% | - | - | -52.49% | -49.65% | -66.04% | -122.16% | -110.22% | -53.98% | -57.61% | -74.35% | -225.25% | -3.55% | -58.85% | -4.22% | -5.98% | -101.06% | -87.15% | -84.01% | -92.9% |
| Net Income Growth % | -6.68% | -21.26% | 338.64% | 70.5% | 31.02% | 22.15% | -84.82% | 49.94% | -1191.91% | 5.52% | -1466.67% | -5093.67% | 94.06% | -15.92% | 92.69% | 90.99% | 28.94% | 58.52% | 4.05% | 34.7% |
| Net Income (Continuing) | -1.33M | -1.96M | -3.33M | -1.32M | -1.21M | -1.58M | -3.09M | -4.11M | -1.76M | -1.73M | -1.34M | -8.21M | -136K | -2.15M | -111K | -158K | -2.29M | -1.86M | -1.52M | -1.75M |
| Discontinued Operations | 40K | 42K | 1000K | 111K | 0 | 0 | -124K | 0 | 0 | -308K | -394K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.22 | -0.33 | 1.42 | -0.27 | -0.60 | -1.37 | -4.92 | -46.53 | -13.11 | -40.92 | -23.13 | -151.72 | -126.40 | -50.05 | -2.71 | -24.14 | -62.42 | -53.51 | -44.51 | -51.43 |
| EPS Growth % | 63.33% | 75.91% | 128.86% | 99.42% | 95.42% | 96.65% | 78.73% | 69.33% | 89.63% | 18.24% | -753.51% | -528.5% | -102.5% | 6.47% | 93.91% | 53.06% | 36.66% | 70.39% | 35.74% | 66.72% |
| EPS (Basic) | -0.22 | -0.33 | 1.44 | -0.27 | -0.60 | -1.37 | -4.92 | -46.53 | -13.11 | -40.92 | -23.13 | -151.72 | -126.40 | -50.05 | -2.71 | -24.14 | -62.42 | -53.51 | -44.51 | -51.43 |
| Diluted Shares Outstanding | 5.88M | 5.82M | 5.42M | 4.88M | 3.71M | 1.16M | 704.91K | 197.06K | 134.06K | 91K | 58.14K | 54.09K | 45.83K | 43.06K | 40.89K | 36.99K | 36.67K | 34.74K | 34.11K | 34.1K |
| Basic Shares Outstanding | 5.88M | 5.82M | 5.31M | 4.88M | 3.71M | 1.16M | 652.91K | 88.29K | 134.06K | 91K | 75.17K | 54.09K | 45.83K | 43.06K | 40.89K | 36.99K | 36.67K | 34.74K | 34.11K | 34.1K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |